Si prevede che il mercato dello screening ad alta produttività raggiungerà i 28.255,71 milioni di dollari entro il 2028 dai 15.997,47 milioni di dollari del 2021. Si stima che il mercato crescerà con un CAGR dell'8,5% dal 2021 al 2028.
Lo screening ad alto rendimento (HTS) è un metodo di scoperta di farmaci che consente il test automatizzato di vari composti chimici o biologici per un bersaglio biologico specifico. I metodi di screening ad alto rendimento sono ampiamente utilizzati nell’industria farmaceutica, sfruttando la robotica e l’automazione per testare rapidamente l’attività biologica o biochimica di un numero significativo di molecole, solitamente farmaci. Accelerano l'analisi dei target, poiché le librerie di composti su larga scala possono presto essere esaminate in modo economicamente vantaggioso. L'HTS è uno strumento prezioso per valutare bersagli farmacologici, profilare farmacologicamente agonisti e antagonisti per recettori (come GPCR) ed enzimi. Fattori come l'aumento degli investimenti in ricerca e ricerca Si prevede che lo sviluppo da parte dell’industria farmaceutica e delle biotecnologie e l’introduzione di prodotti tecnologicamente avanzati nel mercato dello screening ad alta produttività stimoleranno la crescita del mercato nel corso degli anni. Tuttavia, il costo elevato dello screening ad alta produttività, la mancanza di professionisti qualificati e la complessità nello sviluppo dei test probabilmente ostacoleranno la crescita del mercato nei prossimi anni.
Lucrativo Regioni per il mercato dello screening ad alto rendimento
Approfondimenti di mercato
Aumento degli investimenti in ricerca e sviluppo da parte del settore farmaceutico e Industria delle biotecnologie
Un aumento delle spese in ricerca e sviluppo da parte delle aziende farmaceutiche e biotecnologiche e importanti pipeline di farmaci per il trattamento di varie malattie croniche come disturbi cardiovascolari, cancro, disturbi immunologici, disturbi metabolici e disturbi neurologici sono fattori importanti per il mercato dello screening ad alta produttività. Diverse aziende farmaceutiche grandi e piccole sono coinvolte nello sviluppo e nella produzione di nuove molecole per diverse malattie potenzialmente letali. Ciò ha portato alla scelta di metodi automatizzati di screening ad alto rendimento (HTS) per esaminare enormi librerie chimiche per soddisfare le esigenze di molecole bersaglio di farmaci in costante aumento. Ad esempio, un sistema automatizzato di screening ad alta produttività può analizzare da 10.000 a 100.000 composti target in un solo giorno. Negli ultimi dieci anni le aziende farmaceutiche e biotecnologiche hanno investito notevolmente in tecniche di screening ad alta produttività. Ad esempio, la famosa alleanza tra Millennium Pharmaceuticals, Inc. e Bayer AG ha scoperto con successo 18 nuovi bersagli farmacologici e ne ha sottoposti quattro ad uno screening ad alto rendimento in poco meno di otto mesi. L'alleanza adotta un nuovo approccio produttivo basato sulla ricerca genomica per inserire le molecole negli studi clinici il più rapidamente possibile. Lo screening ad alto rendimento è stato considerato una tecnologia vitale nel processo di scoperta dei farmaci. Ad esempio, oltre il 60% dei programmi di ottimizzazione della struttura dei lead completamente sviluppati di Boehringer Ingelheim sono dovuti all'implementazione di successo di HTS. Solo negli Stati Uniti vengono spesi ogni anno più di 2,5 miliardi di dollari USA per prodotti e servizi HTS. Le grandi aziende farmaceutiche investono fino a 35 milioni di dollari all’anno nelle tecnologie di screening. Una parte significativa di questi investimenti è destinata allo sviluppo di nuovi test.
Un numero crescente di farmaci target per lo screening, utilizzati per la scoperta e lo sviluppo di farmaci, e crescenti investimenti da parte del governo e gli istituti di ricerca incoraggeranno ulteriormente l’adozione delle tecniche HTS. Ad esempio, nel dicembre 2020, Sygnature Discovery, un'organizzazione indipendente integrata per la scoperta di farmaci e la ricerca preclinica a contratto con sede nel Regno Unito, ha investito circa 4,12 milioni di dollari per rafforzare il suo servizio di screening ad alto rendimento (HTS) e di oncologia traslazionale. Inoltre, programmi come "Tossicologia nel 21° secolo", una joint venture tra la FDA statunitense, l'Agenzia per la protezione dell'ambiente e l'Istituto nazionale statunitense per la salute, utilizzano HTS automatizzati per testare sostanze chimiche, formulazioni e farmaci ambientali, per un'ampia analisi tossicologica esame e sviluppare percorsi specifici associati alla malattia per prevederne i livelli tossicologici. Tali iniziative sosterranno la proliferazione del mercato dello screening ad alta produttività.
Approfondimenti basati su prodotti e servizi
In base al prodotto e al servizio, il mercato dello screening ad alta produttività è classificato in materiali di consumo, strumenti, accessori, software e servizi. Nel 2021, il segmento dei materiali di consumo deteneva la quota maggiore del mercato e si prevede che assisterà al CAGR più rapido durante il periodo di previsione.
Mercato globale dello screening ad alto rendimento, per prodotto e servizio, 2021 e 2028
Rapporto Copertura
Approfondimenti basati sulla tecnologia
Basato sulla tecnologia, il mercato dello screening ad alta produttività è segmentato in test cellulari, lab-on-a -chip, screening ad altissima produttività, bioinformatica e tecnologia senza etichette. Nel 2021, il segmento dei test basati su celle ha detenuto la quota maggiore del mercato, mentre si prevede che il segmento lab-on-a-chip crescerà al CAGR più rapido durante il periodo di previsione.
< /p>
Approfondimenti basati sull'applicazione
In base all'applicazione, il mercato dello screening ad alto rendimento è segmentato in scoperta di farmaci, screening biochimico, ricerca nelle scienze della vita e altre applicazioni. Nel 2021, il segmento della scoperta di farmaci ha detenuto la quota maggiore del mercato e si prevede che crescerà al CAGR più rapido durante il periodo di previsione.
Approfondimenti basati sull'utente finale
In base all'utente finale, il mercato dello screening ad alta produttività è segmentato in aziende farmaceutiche e biotecnologiche, istituti accademici e governativi, organizzazioni di ricerca a contratto (CRO) e altri. Nel 2021, il segmento delle aziende farmaceutiche e biotecnologiche ha detenuto la quota maggiore del mercato, mentre si prevede che il segmento delle organizzazioni di ricerca a contratto (CRO) crescerà al CAGR più rapido durante il periodo di previsione.
Approfondimenti strategici
Varie aziende che operano nel mercato dello screening ad alta produttività stanno adottando strategie come lanci di prodotti, fusioni e acquisizioni, collaborazioni, innovazioni di prodotto ed espansioni del portafoglio prodotti per espandere la propria presenza in tutto il mondo, mantenere il marchio e soddisfare la crescente domanda da parte degli utenti finali.
Mercato dello screening ad alto rendimento - per prodotto e servizio
- Consumabili
- Reagenti e kit di test
- Attrezzature da laboratorio
- Strumenti
- Sistemi di movimentazione liquidi
- Sistemi di rilevamento
- Accessori
- Software
- Servizi
Mercato dello screening ad alto rendimento - per tecnologia
- Saggi basati su cellule
- Lab-On-A-Chip
- Screening ad altissima produttività
- Bioinformatica
- Tecnologia Label-Free
- Risonanza plasmonica superficiale
- Interferometria riflettente
- Calorimetria di titolazione isotermica
- Calorimetria differenziale a scansione
- Microcantilever
- Nanotubi di carbonio
- Cristalli fotonici
- Altro
Mercato dello screening ad alto rendimento - per applicazione
- Scoperta di farmaci
- Screening biochimico
- Ricerca nel campo delle scienze della vita
- Altre applicazioni
Mercato dello screening ad alto rendimento - per utente finale
- Aziende farmaceutiche e biotecnologiche
- Istituti accademici e governativi
- Organizzazioni di ricerca a contratto (CRO)
- Altro< /li>
Mercato dello screening ad alto rendimento - per area geografica
- Nord America
- Stati Uniti
- Canada
- Messico
< li>Europa - Francia
- Germania
- Italia
- Regno Unito
- Spagna
- Resto dell'Europa
- Asia Pacifico (APAC)
- Cina
- India
- Corea del Sud
- Giappone
- Australia
- Resto dell'Asia Pacifico
- Medio Oriente e Asia Africa (MEA)
- Sudafrica
- Arabia Saudita
- Emirati Arabi Uniti
- Resto del Medio Oriente e dell'Africa. Africa
- America del Sud (SAM)
- Brasile
- Argentina
- Resto dell'America meridionale e centrale< /li>
Profili aziendali
- Agilent Technologies, Inc.
- Axxam SPA
- Eurofins Scientific
- Corning Incorporated
- Molecular Devices, LLC.
- Hamilton Company
- Gruppo Merck
- Perkinelmer , Inc.
- Tecan Group
- Thermo Fisher Scientific Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Global high-throughput screening market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for high-throughput screening. The US is estimated to hold the largest share in the high-throughput screening market during the forecast period. The growth of the market can be because of prevalence of various diseases, government support for biotechnology and increasing efforts in R&D activities as well as other activities undertaken by the market players operating in the market. In addition, technologically advanced products are likely to stimulate the growth of high-throughput screening market in North America. On the other hand, large pool of population suffering with chronic diseases, rapidly developing healthcare infrastructure, and intellectual capabilities of scientists and researchers in the Asia Pacific is expected to account for the fastest growth of the region during the coming years.
The high-throughput screening market majorly consists of the players such Agilent Technologies, Inc., Axxam S.P.A., Eurofins Scientific, Corning Incorporated, Molecular Devices, LLC., Hamilton Company, Merck Group, Perkinelmer, Inc., Tecan Group and Thermo Fisher Scientific Inc. among others.
The consumables segment dominated the global high-throughput screening market and held the largest revenue share of 44.85% in 2021.
The pharmaceutical and biotechnology companies segment dominated the global high-throughput screening market and accounted for the largest revenue share of 45.27% in 2021.
High-throughput screening (HTS) is a drug discovery process that allows automated testing of large numbers of chemical and/or biological compounds for a specific biological target. High-throughput screening methods are extensively used in the pharmaceutical industry, leveraging robotics and automation to quickly test the biological or biochemical activity of a large number of molecules, usually drugs. They accelerate target analysis, as large-scale compound libraries can quickly be screened in a cost-effective way. HTS is a useful tool for assessing for instance pharmacological targets, pharmacologically profiling agonists and antagonists for receptors (such as GPCRs) and enzymes.
Key factors that are driving the growth of this market increase in investment in research and development by the pharmaceutical and biotechnology industry and the introduction of technologically advanced products in the high throughput screening.
The List of Companies - High Throughput Screening Market
- Agilent Technologies, Inc.
- Axxam S.P.A.
- Eurofins Scientific
- Corning Incorporated
- Molecular Devices, LLC.
- Hamilton Company
- Merck Group
- Perkinelmer, Inc.
- Tecan Group
- Thermo Fisher Scientific Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Sep 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Sep 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Sep 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Sep 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Sep 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Sep 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)